BofA analyst Derek Hewett lowered the firm’s price target on Nuveen Churchill (NCDL) to $16.50 from $18.25 and keeps a Buy rating on the shares following what the firm calls “a somewhat mixed quarter.” However, core profitability excluding one-time items was “strong,” says the analyst, who thinks Nuveen Churchill is well positioned to generate strong risk-adjusted returns despite the more challenging macro backdrop.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NCDL:
- Nuveen Churchill price target lowered to $14 from $15 at Wells Fargo
- Nuveen Churchill’s Earnings Call: Mixed Sentiments and Strategic Focus
- Nuveen Churchill reports Q1 EPS 53c, consensus 56c
- Nuveen Churchill Reports Q1 2025 Financial Results
- Nuveen Churchill price target lowered to $16.25 from $18 at UBS